Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain ; volume:15 ; number:1 ; day:24 ; month:12 ; year:2015 ; pages:1-13 ; date:12.2015
BMC cancer ; 15, Heft 1 (24.12.2015), 1-13, 12.2015
- Urheber
-
Lee, Se Jeong
- Beteiligte Personen und Organisationen
-
Kang, Won Young
Yoon, Yeup
Jin, Ju Youn
Song, Hye Jin
Her, Jung Hyun
Kang, Sang Mi
Hwang, Yu Kyeong
Kang, Kyeong Jin
Joo, Kyeung Min
Nam, Do-Hyun
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-2034-y
- URN
-
urn:nbn:de:1111-2016110619710
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Se Jeong
- Kang, Won Young
- Yoon, Yeup
- Jin, Ju Youn
- Song, Hye Jin
- Her, Jung Hyun
- Kang, Sang Mi
- Hwang, Yu Kyeong
- Kang, Kyeong Jin
- Joo, Kyeung Min
- Nam, Do-Hyun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Esophageal natural killer (NK)/T cell lymphoma of true natural killer cell origin
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas
NK cells from RAG- or DCLRE1C-deficient patients inhibit HCMV
Selection and expansion of natural killer cells for NK cell-based immunotherapy
TREM2 promotes natural killer cell development in CD3−CD122+NK1.1+ pNK cells
Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells
Empowering Natural Killer Cells to Combat Acute Myeloid Leukemia: Perspective on CAR-NK Cell Therapy
Natural killer cell line NK-92-mediated damage of medically important fungi
NK cell regulation
Esophageal natural killer (NK)/T cell lymphoma of true natural killer cell origin
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas
NK cells from RAG- or DCLRE1C-deficient patients inhibit HCMV
Selection and expansion of natural killer cells for NK cell-based immunotherapy
TREM2 promotes natural killer cell development in CD3−CD122+NK1.1+ pNK cells
Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells
Empowering Natural Killer Cells to Combat Acute Myeloid Leukemia: Perspective on CAR-NK Cell Therapy
Natural killer cell line NK-92-mediated damage of medically important fungi
NK cell regulation
Esophageal natural killer (NK)/T cell lymphoma of true natural killer cell origin
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas
NK cells from RAG- or DCLRE1C-deficient patients inhibit HCMV
Selection and expansion of natural killer cells for NK cell-based immunotherapy
TREM2 promotes natural killer cell development in CD3−CD122+NK1.1+ pNK cells
Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells
Empowering Natural Killer Cells to Combat Acute Myeloid Leukemia: Perspective on CAR-NK Cell Therapy
Natural killer cell line NK-92-mediated damage of medically important fungi